Top

Published in:

Open Access 01-12-2017 | Erratum

Erratum to: Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?

Authors: Jordi Remon, Benjamin Besse, Jean-Charles Soria

Published in: BMC Medicine | Issue 1/2017

Excerpt

After publication of the original article [1], it came to the publisher’s attention that the text contained several minor typos. Upon investigation, it transpired that there had been technical issues affecting the copyediting process before the article entered the production stage, resulting in the presence of minor errors, without influence on content, in the published version. …

Remon J, Besse B, Soria JC. Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer? BMC Med. 2017;15:55. doi:10.1186/s12916-017-0819-3.CrossRefPubMedPubMedCentral

Title: Erratum to: Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?
Authors: Jordi Remon
Benjamin Besse
Jean-Charles Soria
Publication date: 01-12-2017
Publisher: BioMed Central
Published in: BMC Medicine / Issue 1/2017
Electronic ISSN: 1741-7015
DOI: https://doi.org/10.1186/s12916-017-0857-x

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Erratum to: Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2017

Genetics of vascular dementia – review from the ICVD working group

Post-stroke dementia – a comprehensive review

Simulations for designing and interpreting intervention trials in infectious diseases

Exposure to bacterial products lipopolysaccharide and flagellin and hepatocellular carcinoma: a nested case-control study

Application of real-time global media monitoring and ‘derived questions’ for enhancing communication by regulatory bodies: the case of human papillomavirus vaccines

Disease management in the treatment of patients with chronic heart failure who have universal access to health care: a randomized controlled trial